| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |